Impact of Coronary Anatomy and Stenting Technique on Long-Term Outcome After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease-Reference-Cited by-同舟云学术

Impact of Coronary Anatomy and Stenting Technique on Long-Term Outcome After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease

Published:2014-01 Issue:1 Volume:7 Page:29-36
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Tiroch Klaus,Mehilli Julinda,Byrne Robert A.,Schulz Stefanie,Massberg Steffen,Laugwitz Karl-Ludwig,Vorpahl Marc,Seyfarth Melchior,Kastrati Adnan

Funder

Cordis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Left main drug-eluting stents: natural progression or a bridge too far?;Stone;J Am Coll Cardiol,2007

2. Stents or surgery? New data on the comparative outcomes of percutaneous coronary intervention and coronary artery bypass graft surgery;Hlatky;Circulation,2008

3. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease;Serruys;N Engl J Med,2009

4. Pharmacological prevention and management of restenosis;Tiroch;Expert Opin Pharmacother,2010

5. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction;Kastrati;Eur Heart J,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of failed stenting of the unprotected left main coronary artery;Catheterization and Cardiovascular Interventions;2023-04

2. Non-culprit left main coronary artery disease in acute myocardial infarction complicated by cardiogenic shock;PLOS ONE;2023-03-30

3. Non-Culprit Left Main Coronary Artery Disease in Acute Myocardial Infarction Complicated by Cardiogenic Shock;2022-10-14

4. Predictors of Long-Term Outcomes After Bifurcation PCI;JACC: Asia;2022-10

5. Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial;EuroIntervention;2022-04